News
Mizuho initiated coverage of Embecta (EMBC) with a Neutral rating and $15 price target The firm says its rating balances the company’s ...
Activities include EMS demonstration, station tours, practice using a fire extinguisher and CPR demonstration. 10 a.m.-1 p.m. April 12, Fire Station 37, 911 Wallace Court, Lake Mary, free, ...
Novo Nordisk has made its smart insulin pens available in the UK, giving people treated within the NHS for diabetes access to devices that can monitor and record dosing information for the first time.
The Tempo system brings together a pre-filled insulin pen, the TempoSmart app and a recently-approved Smart Button device that stores and transfers insulin dose-related data from the pen ...
The use of drugs like Ozempic, Wegovy and Zepbound in people with type 1 diabetes has risen sharply over the past decade, a ...
This market research report provides an in-depth analysis of the Injectable Drug Delivery Market, projecting significant ...
A new technology for management of diabetes is cost-effective for patients in the US with type 1 diabetes compared with traditional treatments.
An awful company that obviously does not keep accurate records. As a type 1 diabetic trying to get insulin has been a nightmare. Beginning, November 20, 2024, I have been told my order would ship ...
Health and Me on MSN5d
Meitheal Pharmaceuticals Launch Liraglutide Injections In The USThis new Liraglutide injection is a generic equivalent for Victoza, which is a once-daily noninsulin medicine that lowers ...
Samsung may make a significant change to its popular Galaxy S Ultra phones. The company is thinking about removing the built-in S Pen from its future flagship models. Listen to Story Future Galaxy S ...
As of 12:58:30 pm GMT-4. Market open.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results